(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 7.33%16.14B | 11.31%10.71B | 15.77%4.99B | -5.74%22.34B | -7.80%15.04B | -8.51%9.62B | -10.64%4.31B | -0.84%23.7B | 2.22%16.31B | 1.78%10.52B |
Operating income | 7.33%16.14B | 11.31%10.71B | 15.77%4.99B | -5.74%22.34B | -7.80%15.04B | -8.51%9.62B | -10.64%4.31B | -0.84%23.7B | 2.22%16.31B | 1.78%10.52B |
Operating expenses | -10.08%-14.76B | -12.91%-9.68B | -16.81%-4.51B | 1.42%-20.38B | 8.48%-13.41B | 9.03%-8.58B | 12.93%-3.86B | 0.60%-20.67B | -2.73%-14.65B | -2.42%-9.43B |
Gross profit | -15.27%1.38B | -1.82%1.03B | 6.70%470.86M | -35.28%1.96B | -1.80%1.63B | -3.97%1.04B | 16.03%441.3M | -2.46%3.02B | -2.03%1.66B | -3.50%1.09B |
Selling expenses | -14.02%-92.88M | -19.58%-60.1M | -27.27%-28.43M | -18.30%-141.09M | -9.52%-81.46M | -19.94%-50.25M | 18.84%-22.34M | -21.50%-119.27M | -22.38%-74.38M | -1.25%-41.9M |
Administrative expenses | -0.18%-698.2M | -1.13%-470.89M | 1.89%-233.87M | -6.14%-1.13B | 4.81%-696.97M | -2.53%-465.65M | 4.56%-238.38M | -0.59%-1.07B | -1.27%-732.19M | 4.79%-454.14M |
Research and development expenses | -5.06%-520.51M | 1.54%-315.56M | 23.10%-108.72M | -3.43%-943.31M | -10.67%-495.45M | -20.82%-320.49M | -57.37%-141.38M | -16.11%-912.07M | -16.02%-447.7M | -45.82%-265.26M |
Profit from asset sales | -92.46%297K | -93.59%164K | 89.74%74K | -333.89%-1.97M | 656.24%3.94M | 1,481.27%2.56M | -90.32%39K | -75.01%841K | -87.01%521K | -92.49%161.77K |
Revaluation surplus | --4.84M | --4.84M | --4.84M | --506K | ---- | ---- | ---- | ---- | ---- | ---- |
-Changes in the fair value of other assets | --4.84M | --4.84M | --4.84M | --506K | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provision | 146.26%488.99M | 117.01%183.24M | -44.07%63.9M | -504.02%-2.35B | -443.48%-1.06B | -932.29%-1.08B | -49.18%114.25M | 71.68%-389.79M | 272.32%307.75M | 1,844.37%129.45M |
-Other impairment is provision | 146.26%488.99M | 117.01%183.24M | -44.07%63.9M | -504.02%-2.35B | -443.48%-1.06B | -932.29%-1.08B | -49.18%114.25M | 71.68%-389.79M | 272.32%307.75M | 1,844.37%129.45M |
Special items of operating profit | 261.41%48.39M | 362.69%39.51M | 476.17%25.65M | -74.66%42.28M | -18.11%13.39M | 16.91%8.54M | 183.26%4.45M | 450.17%166.89M | -12.03%16.35M | 134.95%7.3M |
Operating profit | 170.23%535.84M | 139.14%355.99M | 26.72%169.79M | -559.30%-2.69B | -217.42%-762.95M | -324.85%-909.44M | -37.22%133.99M | 251.59%585.91M | 19.88%649.75M | 15.08%404.47M |
Financing cost | -64.78%-191.53M | -220.37%-104.99M | 26.34%-43.28M | 9.77%-259.26M | 58.65%-116.23M | 74.23%-32.77M | 23.13%-58.76M | 48.02%-287.35M | 24.80%-281.07M | 52.17%-127.16M |
Special items of earning before tax | 652.41%45.8M | 506.23%18.33M | 855.78%5.12M | 140.13%5.45M | 70.98%-8.29M | 86.18%-4.51M | -54.43%536K | -574.80%-13.59M | -17.04%-28.57M | -467.57%-32.65M |
Adjustment items of earning before tax | ---- | ---- | ---- | ---- | --1K | ---- | ---- | ---- | ---- | ---- |
Earning before tax | 143.96%390.11M | 128.45%269.33M | 73.74%131.63M | -1,133.39%-2.94B | -360.93%-887.47M | -486.96%-946.72M | -45.16%75.76M | 130.43%284.98M | 136.44%340.12M | 206.45%244.66M |
Tax | -163.98%-93.01M | -153.77%-70.24M | 45.88%-16.38M | 238.34%110.87M | 262.02%145.39M | 314.03%130.62M | -0.25%-30.27M | 24.42%-80.14M | -57.80%-89.73M | -113.42%-61.03M |
After-tax profit from continuing operations | 140.14%297.09M | 124.40%199.09M | 153.35%115.25M | -1,483.58%-2.83B | -395.63%-740.23M | -544.42%-816.11M | -57.86%45.49M | 119.65%204.83M | 187.85%250.39M | 258.36%183.63M |
Special items of earning after tax | ---- | ---- | ---- | ---- | ---1.85M | ---- | ---- | ---- | ---- | ---- |
Adjustment items of earning after tax | ---- | ---- | ---- | ---- | --1.85M | ---- | ---- | ---- | ---- | ---- |
Earning after tax | 140.14%297.09M | 124.40%199.09M | 153.35%115.25M | -1,483.58%-2.83B | -395.63%-740.23M | -544.42%-816.11M | -57.86%45.49M | 119.65%204.83M | 187.85%250.39M | 258.36%183.63M |
Minority profit | 83.51%45.88M | 184.48%43.11M | -73.43%11.29M | -290.60%-176.06M | -74.62%25M | -74.74%15.15M | -2.08%42.47M | 230.40%92.38M | 19.13%98.52M | 25.30%59.99M |
Adjustment items of profit attributable to shareholders | ---- | ---- | ---- | ---- | ---- | ---- | --1K | ---- | --1K | ---- |
Profit attributable to shareholders | 132.83%251.22M | 118.77%155.99M | 3,343.56%103.96M | -2,463.52%-2.66B | -603.88%-765.23M | -772.30%-831.26M | -95.32%3.02M | 110.51%112.46M | 3,444.82%151.87M | 3,573.50%123.64M |
Basic earnings per share | 115.14%0.0421 | 106.67%0.02 | 1,475.00%0.0189 | -24,850.00%-0.8982 | -656.00%-0.278 | -850.00%-0.3 | -94.00%0.0012 | 99.11%-0.0036 | 600.00%0.05 | 500.00%0.04 |
Diluted earnings per share | 115.14%0.0421 | -0.278 | ||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants Limited (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data